# JOURNAL — review phase (Adversary)

## 2026-06-16T00:47:02Z — Phase kickoff
- Phase plan read: review.md (comprehensive deferred verification)
- Current state: Builder has only completed lex and parse phases
  - calc/lexer.py + calc/test_lexer.py (lex phase)
  - calc/parser.py + calc/test_parser.py (parse phase)
  - eval phase NOT yet complete — no evaluator or CLI in calc/
- Created review phase tracking files: STATUS-review.md, REVIEW-review.md, BACKLOG-review.md, JOURNAL-review.md
- Entering wait loop per REVIEW CADENCE (defer to comprehensive single verification)
- Will wake every ~10 min to check if Builder has completed eval phase

## 2026-06-16T00:54:18Z — Comprehensive cold-verification complete

Builder claimed D-all at commit d0e0373. Pulled and ran full verification.

Results summary:
- lex all DoD: PASS
- parse all DoD: PASS
- eval/D1,D2,D4,D5: PASS
- eval/D3 (result type): FAIL — FINDING-1 filed
- 56 tests: PASS
- D3 cross-feature review.md probes: PASS except float literal normalization

FINDING-1: float literals (e.g. `4.0`, `10.`, `-4.0`) not normalized to int.
Root cause: normalization in BinOp branch only (evaluator.py lines 37-38).
Num and Unary branches return raw float value without normalization.
Repro: `python calc.py "4.0"` prints `4.0` not `4`.
Fix: _normalize() helper applied to all return paths in evaluate().

Filed in REVIEW-review.md and BACKLOG-review.md. Pushing review(D-all): FAIL commit.
Awaiting Builder fix then re-verification.

## 2026-06-16T00:57:12Z — Re-verification after Builder fix (FINDING-1)

Builder committed fix at 1cb5f43: extracted _normalize() helper in evaluator.py,
applied to Num, Unary, and BinOp branches. 4 new tests added (60 total).

Re-verification results:
- python calc.py "4.0"  → 4  ✓
- python calc.py "10."  → 10 ✓
- python calc.py "-4.0" → -4 ✓
- python calc.py "0.0"  → 0  ✓
- python -m unittest -q → Ran 60 tests OK ✓
- All original verification commands still pass ✓

FINDING-1 CLOSED. review(D-all): PASS committed and pushed.
Builder may now write ## DONE to STATUS-review.md.